Our World Class Team
Dr. Steve Ruston PhD – Chief Executive Officer
Dr. Ruston completed a PhD in synthetic organic chemistry at the University of Leeds
His career path in Pharma & the Fine Chemicals sectors has provided wide-ranging roles in pharmaceutical R&D, chemical manufacturing & site operations with key roles in Smith Kline, Courtaulds, GlaxoWellcome & Pfizer in the UK, USA & Latin America.
He contributed to the teams responsible for the development and commercial success of Tagamet, Zantac, Imigran and Viagra and was responsible for the design, commissioning and operation of R&D laboratory and chemistry pilot plant facilities with a capital value in excess of £300m.
As CEO he led the growth and development of a UK-based biotechnology company from its university spinout stage through to a successful sale to an international Pharmaceutical company.
Dr. Ruston’s management responsibilities include all aspects of running a business including direction of scientific teams and projects, finance, legal, human resources and operations.
Dr. Alan A Jordan DC PhD
Dr. Jordan qualified as a Chiropractor at the University of Toronto in 1979. Post-graduate degrees were carried out at the University of Copenhagen in 1991 (MSc) and in 1997 he completed a doctorate in medical research at the Faculty of Medicine, Royal National University Hospital, Copenhagen.
He worked as an associate professor & course coordinator, Faculty of Sports Medicine & Clinical Biomechanics, University of Southern Denmark 1998-2003 and was a research and faculty consultant, Spine Centre, University Hospital Ringe, Denmark 1998-2010.
He has published extensively in peer-reviewed journals and co-authored two books on spinal pain and was awarded Scandinavian researcher of the year in 1997 by The Danish Society of Musculoskeletal Disease.
Charity work includes the Danish Association for Arthritis and several patient associations. He is currently a Director of the Broadgate Spine & Joint Clinic, London and a Board Member of the MAST Medical Academy.
Sarah Guest MSc - Operations & Project Director
Sarah Guest gained her BSc in Biochemistry from Kent University and subsequently her MSc in Epidemiology from the London School of Hygiene and Tropical Medicine.
During her 19-year career at Pfizer, Sarah progressed to Director within Global Project Management. She has extensive experience across all phases of drug development and multiple therapeutic areas, and played a key role in the successful registration and approval of Relpax TM. Biotechnology experience has been gained at ProtAffin Biotechnologie AG, an Austrian based company, where she was involved in the execution of the company’s first clinical study.
Dr. Lloyd Czaplewski PhD – Chief Scientific Officer
Dr. Czaplewski was awarded a PhD in Molecular Genetics from the University of Glasgow and followed this with postdoctoral research studies at the University of Leeds.
He then embarked on a career path of the highest scientific and technical calibre working in the biotechnology sector and key positions included Head of Biology at British Biotech, UK and Vice President R&D, Prolysis and Biota (Europe).
His R&D experience has been gained in multiple therapeutic areas from fundamental research to clinical evaluation and in particular he is recognized as a leading expert in the discovery, development
Dr. Czaplewski has published numerous scientific papers in leading journals as well as filing multiple patent applications.
He is working with a number of academic technology transfer groups and consults for the Wellcome Trust and has a successful track record working at Board level to assist in corporate fundraising, commercial deal discussions and patent assignments.
Mr. Peter J Hamlyn, Consultant Spinal Surgeon
Mr. Hamlyn graduated from UCL Medical School in 1982 and became a Fellow of the Royal College of Surgeons in 1986. He was awarded the Roger’s Prize in 1993 and became a Fellow of the Institute of Sports Medicine in 1996.
Current positions include Director of Education, Institute of Sport Exercise and Health at UCL, Vice Chairman, Brain and Spine Foundation, Chairman, Foundation for Human Potential, and Directorships at the Broadgate Spine & Joint Clinic and The Spine Surgery London.
From July 2004 – July 2005 he was a Member of the 2012 Olympic Bid Advisory Panel. Research Activity includes a period as Convener of Queen Mary University of London Spinal Cord Injury Group – a £750,000 funded research program & a grant from the Migraine trust.
Author of one neurosurgical text book (2000) and multiple publications in peer review journals and presentations to learned societies.
He is a member of the International Symposia on Concussion in Sport: Prague and Zurich.
Marie Lossky PhD – Intellectual Property Consultant
Persica has been financed by individual private investors based in the UK, Scandinavia and the United States since its establishment in 2013.
The shareholder register includes physicians/surgeons, patients, international financiers, lawyers and senior executives from the pharmaceutical sector
We have not received institutional or corporate funding and our shareholder base has demonstrated long term support and commitment to our Company.